In prostate cancer, silencing Hsp27 can decrease IL-6-dependent STAT3 phosphorylation, nuclear translocation, and STAT3 targeting of the Twist promoter, indicating that Hsp27 is required for IL-6-mediated EMT via regulation of STAT3/Twist signaling [17]. The gene discussed is TWIST1; the disease is prostate carcinoma.